CHFA:全国心力衰竭日11.26—指导患者认识心衰,早诊早治!

2016-11-07 心衰专委会 心力衰竭网

心力衰竭(简称“心衰”)作为心血管疾病的终末阶段,患病人数在持续增长,是21世纪心血管疾病面临的严重挑战,但大多数人对心力衰竭的认知度和重视程度都极低。为更好地提高全民对心衰的认知和关注,由国家心血管病中心、中国医师协会心力衰竭专业委员会、中国健康促进与教育协会、中国心力衰竭防治工程共同发起的第二次“全国心力衰竭日”即将开展。下面和小编一起来关注2016年11月26日——“全国心力衰竭日”吧!

心力衰竭(简称“心衰”)作为心血管疾病的终末阶段,患病人数在持续增长,是21世纪心血管疾病面临的严重挑战,但大多数人对心力衰竭的认知度和重视程度都极低。为更好地提高全民对心衰的认知和关注,由国家心血管病中心、中国医师协会心力衰竭专业委员会、中国健康促进与教育协会、中国心力衰竭防治工程共同发起的第二次“全国心力衰竭日”即将开展。下面和小编一起来关注2016年11月26日——“全国心力衰竭日”吧!  

一、心衰是什么?

你知道什么是心衰吗?


♥1.心衰的死亡率和癌症相当,70岁以上老人中,每10个人可能就有一个人患有心衰。

♥2.心力衰竭也称心功能不全,是心血管病发展到了严重的阶段,心脏的泵血功能衰退,就像弹性减退的“皮球”,输出血量不能够满足身体代谢的需要,器官和组织中的血液也不能顺利回流到心脏,这种状态就叫做心力衰竭。

♥3.心衰是一种严重的临床综合征,可能出现呼吸困难、乏力、水肿(尤其下肢)等表现。

心衰有什么危害?

♥1.心衰是一种进展性疾病。随着疾病的发展,临床症状会不断加重,甚至影响生命。


♥2.心衰会直接影响您的社交、限制日常活动,还会带来抑郁、焦虑等负面情绪
♥3.心衰会给自己、家庭和社会带来严重的经济负担
♥4.心衰可能需要经常住院,而且心衰的死亡率很高


二、心衰距离你有多远?

心衰其实并不遥远,如果您有以下疾病(或病史),您可能就是心衰的高风险人群,一旦发现有心衰的症状就应该去医院专科就诊,不要漏掉以下病史,千万不可以掉以轻心:


♥1.冠心病是心衰最常见的病因;高血压是心衰的主要危险因素。如果您有冠心病或者高血压,平时应该多量血压,定期做心电图检查,多注意心脏保健。


♥2.糖尿病,肥胖,代谢综合症患者,也是心衰的常见病因。平时多注意清淡饮食,控制体重,少吃多餐,因为饱餐也有可能引起心衰。

♥3.还有,如果您有心脏毒性药物史、风湿热病史、心肌病家族史等,平时就应该注意有没有出现心衰的症状,因为这些都是心衰的高风险因素。

三、哪些症状是心衰信号?

♥1.如果您是心脏病或高血压患者,在过度劳累或者情绪波动以后,出现了呼吸困难、不能平躺、心悸、下肢水肿等表现,应该及早到心血管专科就诊

♥2.如果您不知道既往有没有心脏病史,突然感到喘不上气、心慌、特别疲乏、甚至脚踝、腿出现水肿,应该尽快就医,排除心衰的可能

♥3.如果以往的心电图或心脏超声出现过异常,当时未诊断为心衰,而后来出现了气喘、呼吸困难、疲劳乏力的表现,应该及时到医院心脏专科就诊

♥提示:到医院就诊不要忘记随身携带既往心电图、心脏超声和胸部X线的报告单,可以作为诊断参考


四、心衰到底严重吗?
 
你知道病历和化验单上的结果都有哪些含义吗? 

♥NYHA分级(纽约心功能分级):用来评价心功能受损的程度。按照诱发心衰的活动程度把心功能的受损状况分为四个等级,I级最轻,IV级最严重。NYHA分级帮助心衰患者和医生简易地了解心功能受损和病情严重程度,可以帮助选择合适的检查、治疗方案。




 


五、你知道心衰检查有哪些吗?

♥BNP(脑钠肽): 用来诊断心衰、评估心衰严重程度和治疗效果的生物标志物。反映的是左右心室、心脏瓣膜的功能。血浆BNP>80ng/L,诊断无症状心衰敏感性高,有利于心衰早期诊断,早期治疗。BNP也可以评估慢性心衰的严重程度和预后,BNP值越高,心衰的预后越差。另外,BNP可以辅助评价心衰治疗效果,降低病死率和住院风险。

如果是怀疑心衰的患者,检查显示BNP≥35pg/ml(或NT-proBNP≥125pg/ml),应及时检查超声心动图,排除心衰的可能。


♥超声心动图:用来评估心脏的结构、功能状况。心超可以准确地反应心脏结构、搏动和血液流动的情况。您可以关注心超最主要的指标:LVEF(左心室射血分数),如果LVEF低于50%,一般视为心功能不全。


♥提示:如果通过上述检查确诊为心衰,那就需要积极配合医生进行治疗。千万不可掉以轻心或擅自用药。

六、得了心衰应该怎么治?

心衰如何早预防、早治疗?

♥心衰是一种进展性的疾病,重在预防。越早治疗,效果越好。如果不及时治疗,心衰的症状会越来越严重,每一次的加重都会给心脏带来不可逆的伤害。

♥心衰的药物治疗:心衰药物治疗“金三角”是ACEI/ARB,醛固酮受体拮抗剂,β受体阻滞剂。药物治疗应该遵循“足量、足疗程”的原则。(ACEI的作用是改善心肌重构,保护心脏;β受体阻滞剂可以降低心脏负担,改善心脏功能;醛固酮受体拮抗剂改善心脏舒张和收缩功能)
 
ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB

 ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB        
注:ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB

♥ 心衰非药物治疗:经优化药物治疗,仍为NYHA Ⅱ- Ⅳ级且LVEF ≤ 35%,可实施CRT(心脏再同步化治疗)

七、心衰治疗药物是如何发挥作用的?









八、心衰患者如何调整生活方式?


♥心衰患者应注意限水
心衰会导致身体内的水钠潴留,即过多的水留在心脏。反过来水钠潴留又会促进心衰症状的出现
1.严重心衰患者,液体摄入量限制在1.5-2.0/天,有助于减轻症状和充血
2.严重低钠血症(血钠< 130mmol/L)患者。液体摄入量应< 2L/天
3.轻中度症状患者常规限制液体摄入并无益处

限制饮水的方法


找出喝水的杯子、做好记号
不口渴,不要饮水
如果嘴干,可以尝试含一块冰、糖等
需要关注每天所吃的药物、水果中的含水量
腿肿、心衰加重患者应保证每天的入量比出量略少或者平衡,患者和家人应学会记录每天出入量

♥2.心衰患者应注意限盐
心衰患者应适当控制每日盐的摄入量,应比一般食盐偏少,这样对控制NYHAⅢ-Ⅳ级心衰患者的充血症和体征有帮助

轻度心力衰竭患者,每天摄入钠盐量限制在2克,实际相当于食盐5克
中度心力衰竭患者,每天摄入钠盐量限制在1克,实际相当于食盐2.5克
重度心力衰竭患者,每天摄入钠盐量限制在0.4克,实际相当于食盐1克

服用利尿剂时不需要严格限盐
对于心衰患者,服用利尿剂时,排尿多,所以盐也要适当增加,如果盐不足会造成患者不易利尿。另外,服用利尿剂的患者一定要注意补钾,以免出现低血钾问题;肾功能不全的患者补钾期间,应定期复查电解质,避免血钾过高造成的危险。

减少下列盐高的食品摄入
腌制、熏制的食品,如酱菜、咸肉、香肠
添加小苏打的面食和糕点等
咸味浓的快餐,如汉堡包,油炸土豆等
含纳调味品,如番茄酱、蛋黄酱、酱油、沙拉酱等
含盐饮料

♥除了限水限盐,心衰患者还应该注意注意以下:
戒烟戒酒,低脂清淡饮食,肥胖的患者要适当减重。还应少食多餐,因为饱餐可诱发或加重心衰;注意适度的休息和运动,多与家人朋友沟通排除焦虑和孤独等负面情绪;同时还应该学会自我监测:填写日常管理记录表,每天检查脚踝、腿有没有水肿,注意不要过度运动,避免感染等。

九、心衰患者有哪些自我管理的妙招呢?

每日症状观察

♥1.每日称重:
患者每日的称重需保持在早晨,排尿后、进食之前进行
每天和前一天,前一周的体重情况进行比较

♥2.每日检查水肿
每天检查腿是否膨胀或身体其他部位存在水肿增长
 
♥3.监测运动耐量
记录气短症状:没有气短、气短在稍用力后、气短在剧烈用力后、气短在静息时等
 
♥4.监测夜间呼吸情况 
记录夜间呼吸:能平卧、需要两个枕头或更多、端坐呼吸或被夜间的气短憋醒等
♥5.注意头晕
记录头晕:从不头晕、站立后头晕、几乎晕厥/晕厥
 
如有以上症状的加重,提示心衰恶化,需及时通知医生

日常管理记录表
 
就诊记录表

参考文献:
1.中国心力衰竭的流行病学概况[J]. 中华心血管病杂志, 2015, 43(12).
2.Gerberet al. JAMA Intern Med 2015;175:996-1004
3.AhmedA. A propensity matched study of New York Heart Association class and naturalhistory end points in heart failure. Am J Cardiol. 2007;99(4):549-553
4.中华医学会心血管病学分会. 中华心血管病杂志. 2014; 42(2):98-122
5.European Society of Cardiology, European Heart Journal, 2016, 18.
6.钱海兰.中华现代护理杂志, 2008, 14(13):188-188.
7.周京敏, 崔晓通, 葛均波. 中国心力衰竭的流行病学概况[J]. 中华心血管病杂志, 2015, 43(12).
8.中国心力衰竭的流行病学概况[J]. 中华心血管病杂志, 2015, 43(12).
9. Gerber et al. JAMA Intern Med 2015;175:996-1004
10.Ahmed A. A propensity matched study of NewYork Heart Association class and natural history end points in heart failure.Am J Cardiol. 2007;99(4):549-553
MCC批号LOT1610582 有效期2017-11-04,过期资料,视同作废

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
    2017-04-05 DEXTER3139
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
    2016-11-10 laoli

    谢谢分享!学习了!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
    2016-11-09 thlabcde

    什么事情都得早!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
    2016-11-09 老段

    学习了,赞一个!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
    2016-11-07 inter158

    认真学习心衰图解很好!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
    2016-11-07 明崖

    学习了,心衰原来如此发病和治疗

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1952280, encodeId=0763195228045, content=<a href='/topic/show?id=b3b546305b' target=_blank style='color:#2F92EE;'>#CHF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4630, encryptionId=b3b546305b, topicName=CHF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Apr 05 08:05:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154852, encodeId=fae615485275, content=谢谢分享!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Thu Nov 10 17:27:35 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154650, encodeId=1e4915465033, content=什么事情都得早!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Nov 09 22:43:25 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154472, encodeId=cd4c1544e228, content=学习了,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Nov 09 07:04:04 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591210, encodeId=852615912107b, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Wed Nov 09 04:05:00 CST 2016, time=2016-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154198, encodeId=eaab154198b1, content=认真学习心衰图解很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Mon Nov 07 23:54:32 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154164, encodeId=1bbc154164dc, content=学习了,心衰原来如此发病和治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Nov 07 21:00:54 CST 2016, time=2016-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154088, encodeId=d3f91540881f, content=ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKDtuWHtWxToIW0ZEvbHgDb4ibqQ1xaDQxcsHC5NIc2RJUxQgHJOLGEg8OUT345rDPmka4icU0WHPgw/0, createdBy=379f1941464, createdName=艳阳天2016, createdTime=Mon Nov 07 14:20:57 CST 2016, time=2016-11-07, status=1, ipAttribution=)]
    2016-11-07 艳阳天2016

    ACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARBACEI是心衰的基石和首选药物,不能耐受ACEI的患者可用ARB重要的事情需要说多少遍?

    0

相关资讯

GW-ICC 2016:吴永健教授谈冠心病血运重建策略如何落地基层医院?

▲ 吴永健教授第二十七届长城国际心血管病会议期间,县域医疗联盟成立后第一次正式会议——县域医疗论坛召开,旨在对基层医师培训冠心病治疗相关技术和理念。一个国家现代化发展水平的高低,往往体现在医疗现代化水平。我国各地区间医疗水平发展不平衡,县级医院数量庞大又承上启下,是我国医疗体系的重要组成部分,因此提高县级医院的诊疗技术水平势在必行。本次会议期间,中国医学科学院阜外医院的吴永健教授详细阐述了冠心

Circulation:首次住院治疗心力衰竭后能重返职场吗?

由此可见,在心衰住院前还在工作岗位的患者死亡率较低,但是1年后无法返回工作的风险较高。较小的年龄、男性和更高的教育水平可作为返回工作的预测指标。

盘点:近期心力衰竭治疗指南共识一览

心力衰竭(heart failure)简称心衰,是指由于心脏的收缩功能和(或)舒张功能发生障碍,不能将静脉回心血量充分排出心脏,导致静脉系统血液淤积,动脉系统血液灌注不足,从而引起心脏循环障碍症候群,此种障碍症候群集中表现为肺淤血、腔静脉淤血。心力衰竭并不是一个独立的疾病,而是心脏疾病发展的终末阶段。其中绝大多数的心力衰竭都是以左心衰竭开始的,即首先表现为肺循环淤血。梅斯医学小编为大家盘点,近

Heart:儿童心力衰竭新生物标志物的诊断性能及参考值

由此可见,中段ProANF能精确检测儿童和青少年中的心衰患者,其诊断性能与NT-proBNP媲美。

Sci Adv:鉴别出引发机体心力衰竭的关键遗传标记

近日,刊登在国际杂志Science Advances上的一篇研究报告中,来自德克萨斯大学健康科学中心及贝勒医学院的研究人员通过鉴别出了充血性心力衰竭的指示器,在美国,充血性心力衰竭是引发患者住院和死亡的主要原因,同时文章中研究者还揭示了基因突变影响机体代谢产物循环的机制。 人类机体的代谢组是一系列名为代谢产物的小分子集合,其源于机体代谢过程,同时其在指示疾病上也扮演着重要角色;这项研究中,研究者

JAMA Cardiol:贫血常见于心力衰竭患者中,且常与铁缺乏相关

流行病学上,关于慢性心力衰竭门诊病人贫血和铁缺乏的患病率、相互关联和结果方面的详细信息尚缺乏。本研究旨在大量临床上疑似心力衰竭的病人中调查贫血和铁缺乏的情况。 2001年1月1日到2010年12月31日期间,研究人员收集了同一家社区门诊就诊的疑似心力衰竭病人的临床数据,包括血红素,血清铁,运铁蛋白饱和度和血清铁蛋白浓度。随访数据截止至2011年12月13日。超声心电图和血浆N端脑钠肽测定对患